These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 34347975)

  • 1. Differential Expression of miRNA in the Peripheral Blood Mononuclear Cells in Myasthenia Gravis with Muscle-Specific Receptor Tyrosine Kinase Antibodies.
    Tan Y; Zhu L; Cui L; Guan Y
    Crit Rev Eukaryot Gene Expr; 2021; 31(2):1-15. PubMed ID: 34347975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estrogen Receptor, Inflammatory, and FOXO Transcription Factors Regulate Expression of Myasthenia Gravis-Associated Circulating microRNAs.
    Fiorillo AA; Heier CR; Huang YF; Tully CB; Punga T; Punga AR
    Front Immunol; 2020; 11():151. PubMed ID: 32153563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating microRNAs as potential biomarkers in myasthenia gravis patients.
    Punga AR; Punga T
    Ann N Y Acad Sci; 2018 Jan; 1412(1):33-40. PubMed ID: 29125182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating miRNAs as Potential Biomarkers in Myasthenia Gravis: Tools for Personalized Medicine.
    Sabre L; Punga T; Punga AR
    Front Immunol; 2020; 11():213. PubMed ID: 32194544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating microRNA plasma profile in MuSK+ myasthenia gravis.
    Sabre L; Guptill JT; Russo M; Juel VC; Massey JM; Howard JF; Hobson-Webb LD; Punga AR
    J Neuroimmunol; 2018 Dec; 325():87-91. PubMed ID: 30316681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease specific enrichment of circulating let-7 family microRNA in MuSK+ myasthenia gravis.
    Punga T; Bartoccioni E; Lewandowska M; Damato V; Evoli A; Punga AR
    J Neuroimmunol; 2016 Mar; 292():21-6. PubMed ID: 26943954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential Cytokine Changes in Patients with Myasthenia Gravis with Antibodies against AChR and MuSK.
    Yilmaz V; Oflazer P; Aysal F; Durmus H; Poulas K; Yentur SP; Gulsen-Parman Y; Tzartos S; Marx A; Tuzun E; Deymeer F; Saruhan-Direskeneli G
    PLoS One; 2015; 10(4):e0123546. PubMed ID: 25893403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA expression profiles of peripheral blood and mononuclear cells in myasthenia gravis: A systematic review.
    Saghazadeh A; Rezaei N
    Int Immunopharmacol; 2022 Nov; 112():109205. PubMed ID: 36087508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MuSK myasthenia gravis presenting with purely ocular findings.
    Caress JB; Hunt CH; Batish SD
    Arch Neurol; 2005 Jun; 62(6):1002-3. PubMed ID: 15956173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effect of low-dose rituximab on myasthenia gravis with muscle-specific tyrosine kinase antibody.
    Zhou Y; Yan C; Gu X; Zhou L; Lu J; Zhu W; Huan X; Luo S; Zhong H; Lin J; Lu J; Zhao C; Xi J
    Muscle Nerve; 2021 Jun; 63(6):824-830. PubMed ID: 33745138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of serum exosome miRNA as a biomarker for early onset adult ouclar myastthenia gravis.
    Mu Y; Huang X; Yang Y; Huang Z; Chen J; Li S; Dong Y; Chen F; Zhang R; Chen J; Feng H; Zhou Q
    Gene; 2024 Feb; 896():148034. PubMed ID: 38013129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical features of myasthenia related with autoantibodies to muscle specific tyrosine kinase (MuSK)].
    Sanadze AG; Sidnev DV; Karganov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(12):72-6. PubMed ID: 21311492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MuSK antibody positive myasthenia gravis plasma modifies MURF-1 expression in C2C12 cultures and mouse muscle in vivo.
    Benveniste O; Jacobson L; Farrugia ME; Clover L; Vincent A
    J Neuroimmunol; 2005 Dec; 170(1-2):41-8. PubMed ID: 16213598
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MuSK antibody-positive, seronegative myasthenia gravis in Korea.
    Lee JY; Sung JJ; Cho JY; Oh DH; Kim HJ; Park JH; Lee KW; Choi YC; Vincent A
    J Clin Neurosci; 2006 Apr; 13(3):353-5. PubMed ID: 16546389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysautonomia as the Presenting Symptom in Anti-Muscle-Specific Kinase Antibody Myasthenia Gravis.
    Bekooij TJS; Gilhuis HJ; Dawson L; Niks EH
    J Neuromuscul Dis; 2020; 7(1):47-50. PubMed ID: 31868676
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ["Seronegative" myasthenia with antibodies against muscle-specific tyrosine-kinase].
    Hain B; Hanisch F; Deschauer M
    Nervenarzt; 2004 Apr; 75(4):362-7. PubMed ID: 15042294
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel infection- and inflammation-associated molecular signature in peripheral blood of myasthenia gravis patients.
    Barzago C; Lum J; Cavalcante P; Srinivasan KG; Faggiani E; Camera G; Bonanno S; Andreetta F; Antozzi C; Baggi F; Calogero RA; Bernasconi P; Mantegazza R; Mori L; Zolezzi F
    Immunobiology; 2016 Nov; 221(11):1227-36. PubMed ID: 27387891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.
    Rivner MH; Pasnoor M; Dimachkie MM; Barohn RJ; Mei L
    Neurol Clin; 2018 May; 36(2):293-310. PubMed ID: 29655451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.
    Koneczny I; Cossins J; Vincent A
    J Anat; 2014 Jan; 224(1):29-35. PubMed ID: 23458718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of myasthenia gravis with anti-muscle specific kinase antibodies in The Netherlands.
    Niks EH; Kuks JB; Verschuuren JJ
    J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):417-8. PubMed ID: 17056627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.